Gyre Therapeutics, Inc.

GYRE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K May 4, 2026 8-K
ARS Apr 27, 2026 ARS
DEFA14A Apr 27, 2026 DEFA14A
DEF 14A Apr 27, 2026 DEF 14A
8-K/A Apr 17, 2026 8-K/A
PRE 14A Apr 16, 2026 PRE 14A
8-K Mar 23, 2026 8-K
10-K Mar 13, 2026 10-K
8-K Mar 12, 2026 8-K
8-K Mar 12, 2026 8-K
8-K Mar 2, 2026 8-K
4 Jan 9, 2026 FORM 4
4 Jan 9, 2026 FORM 4
8-K Jan 5, 2026 FORM 8-K
144 Nov 13, 2025
10-Q Nov 7, 2025 10-Q
8-K Nov 7, 2025 8-K
8-K Sep 10, 2025 8-K
4 Aug 26, 2025 FORM 4
3 Aug 26, 2025 FORM 3
8-K Aug 22, 2025 8-K
10-Q Aug 11, 2025 10-Q
8-K Aug 11, 2025 8-K
4 Aug 7, 2025 FORM 4
4 Jun 6, 2025 FORM 4
← Newer Page 3 of 65 · 1601 filings Older →